Vaxxas announces promising results in skin patch vaccine trial: A revolution in immunization
Vaxxas, a clinical-stage biotechnology company, has achieved a significant milestone in vaccine delivery technology. The company’s innovative high-density microarray patch (HD-MAP) technology, which enables vaccines to be administered through a skin patch, has shown positive results in a human clinical trial. Clinical Trial by University of the Sunshine Coast Reveals Encouraging Data Conducted by the […]
